• Home
  • Search Results
  • Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.

Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.

Neurobiology of aging (2014-03-13)
Noemí Fabelo, Virginia Martín, Raquel Marín, Dolores Moreno, Isidre Ferrer, Mario Díaz
ABSTRACT

The presence of lipid alterations in lipid rafts from the frontal cortex in late stages of Alzheimer's disease (AD) has been recently demonstrated. Here, we have isolated and analyzed the lipid composition of lipid rafts from different brain areas from control and AD subjects at initial neuropathologic stages. We have observed that frontal cortex lipid rafts are profoundly altered in AD brains from the earliest stages of AD, namely AD I/II. These changes in the lipid matrix of lipid rafts affected both lipid classes and fatty acids and were also detected in the entorhinal cortex, but not in the cerebellum from the same subjects. Paralleling these changes, lipid rafts from AD frontal and entorhinal cortices displayed higher anisotropy for environment-sensitive probes, indicating that lipid changes in AD lipid rafts increased membrane order and viscosity in these domains. The pathophysiological consequences of these alterations in the development and progression of AD were strengthened by the significant, and specific, accumulation of β-secretase within the lipid rafts of AD subjects even at the earliest stages. Our results provide a mechanistic connection between lipid alterations in these microdomains and amyloidogenic processing of amyloid precursor protein.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,6-Diphenyl-1,3,5-hexatriene, 98%
Sigma-Aldrich
Anti-APP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-APP antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
Sigma-Aldrich
Anti-APP antibody produced in rabbit, 1 mg/mL, affinity isolated antibody
Sigma-Aldrich
Anti-APP antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-APP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-APP (Ab-668) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-APP (ab2) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-APP (ab3) antibody produced in rabbit, IgG fraction of antiserum